The global market for Human Rabies Immunoglobulin (IM) was valued at US$ 327 million in the year 2024 and is projected to reach a revised size of US$ 407 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Human Rabies Immunoglobulin (IM) Market

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization. In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

The rising incidence of rabies, especially in developing countries, is a key driver of the human rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes human rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for human rabies immunoglobulin in both rural and urban areas.

A major challenge in the human rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.

Asia-Pacific is expected to experience the highest growth in the market during the forecast period.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Rabies Immunoglobulin (IM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Immunoglobulin (IM).

The Human Rabies Immunoglobulin (IM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Rabies Immunoglobulin (IM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Rabies Immunoglobulin (IM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Rabies Immunoglobulin (IM) Market Report

Report Metric	Details
Report Name	Human Rabies Immunoglobulin (IM) Market
Accounted market size in year	US$ 327 million
Forecasted market size in 2031	US$ 407 million
CAGR	3.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	ERIG HRIG
Segment by Application	Category II Exposure Category III Exposure
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, Tiantan Bio, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rabies Immunoglobulin (IM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rabies Immunoglobulin (IM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Rabies Immunoglobulin (IM) Market growing?

Ans: The Human Rabies Immunoglobulin (IM) Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Human Rabies Immunoglobulin (IM) Market size in 2031?

Ans: The Human Rabies Immunoglobulin (IM) Market size in 2031 will be US$ 407 million.

Who are the main players in the Human Rabies Immunoglobulin (IM) Market report?

Ans: The main players in the Human Rabies Immunoglobulin (IM) Market are CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, Tiantan Bio, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS

What are the Application segmentation covered in the Human Rabies Immunoglobulin (IM) Market report?

Ans: The Applications covered in the Human Rabies Immunoglobulin (IM) Market report are Category II Exposure, Category III Exposure

What are the Type segmentation covered in the Human Rabies Immunoglobulin (IM) Market report?

Ans: The Types covered in the Human Rabies Immunoglobulin (IM) Market report are ERIG, HRIG

1 Human Rabies Immunoglobulin (IM) Market Overview

1.1 Product Definition

1.2 Human Rabies Immunoglobulin (IM) by Type

1.2.1 Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Type (2024 VS 2031)

1.2.2 ERIG

1.2.3 HRIG

1.3 Human Rabies Immunoglobulin (IM) by Application

1.3.1 Global Human Rabies Immunoglobulin (IM) Market Value by Application (2024 VS 2031)

1.3.2 Category II Exposure

1.3.3 Category III Exposure

1.4 Global Human Rabies Immunoglobulin (IM) Market Size Estimates and Forecasts

1.4.1 Global Human Rabies Immunoglobulin (IM) Revenue 2020-2031

1.4.2 Global Human Rabies Immunoglobulin (IM) Sales 2020-2031

1.4.3 Global Human Rabies Immunoglobulin (IM) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Human Rabies Immunoglobulin (IM) Market Competition by Manufacturers

2.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Human Rabies Immunoglobulin (IM), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application

2.7 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Date of Enter into This Industry

2.8 Global Human Rabies Immunoglobulin (IM) Market Competitive Situation and Trends

2.8.1 Global Human Rabies Immunoglobulin (IM) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue

2.8.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Human Rabies Immunoglobulin (IM) Market Scenario by Region

3.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2020-2031

3.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2020-2025

3.2.2 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2026-2031

3.3 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2020-2031

3.3.1 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2020-2025

3.3.2 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2026-2031

3.4 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country

3.4.1 North America Human Rabies Immunoglobulin (IM) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)

3.4.3 North America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country

3.5.1 Europe Human Rabies Immunoglobulin (IM) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)

3.5.3 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Rabies Immunoglobulin (IM) Market Facts & Figures by Region

3.6.1 Asia Pacific Human Rabies Immunoglobulin (IM) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2020-2031)

3.6.3 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country

3.7.1 Latin America Human Rabies Immunoglobulin (IM) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)

3.7.3 Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2031)

4.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)

4.1.2 Global Human Rabies Immunoglobulin (IM) Sales by Type (2026-2031)

4.1.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2031)

4.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2031)

4.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2025)

4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2026-2031)

4.2.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2031)

4.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2020-2031)

5.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)

5.1.2 Global Human Rabies Immunoglobulin (IM) Sales by Application (2026-2031)

5.1.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2031)

5.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2031)

5.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2025)

5.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2026-2031)

5.2.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2020-2031)

5.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Company Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Company Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Grifols Human Rabies Immunoglobulin (IM) Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Company Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sanofi Human Rabies Immunoglobulin (IM) Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Sichuan Yuanda Shuyang

6.4.1 Sichuan Yuanda Shuyang Company Information

6.4.2 Sichuan Yuanda Shuyang Description and Business Overview

6.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolio

6.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates

6.5 Tiantan Bio

6.5.1 Tiantan Bio Company Information

6.5.2 Tiantan Bio Description and Business Overview

6.5.3 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Tiantan Bio Human Rabies Immunoglobulin (IM) Product Portfolio

6.5.5 Tiantan Bio Recent Developments/Updates

6.6 Kamada

6.6.1 Kamada Company Information

6.6.2 Kamada Description and Business Overview

6.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Kamada Human Rabies Immunoglobulin (IM) Product Portfolio

6.6.5 Kamada Recent Developments/Updates

6.7 CBPO

6.7.1 CBPO Company Information

6.7.2 CBPO Description and Business Overview

6.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 CBPO Human Rabies Immunoglobulin (IM) Product Portfolio

6.7.5 CBPO Recent Developments/Updates

6.8 Shuanglin Bio

6.8.1 Shuanglin Bio Company Information

6.8.2 Shuanglin Bio Description and Business Overview

6.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolio

6.8.5 Shuanglin Bio Recent Developments/Updates

6.9 Weiguang Bio

6.9.1 Weiguang Bio Company Information

6.9.2 Weiguang Bio Description and Business Overview

6.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolio

6.9.5 Weiguang Bio Recent Developments/Updates

6.10 Shanghai RAAS

6.10.1 Shanghai RAAS Company Information

6.10.2 Shanghai RAAS Description and Business Overview

6.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolio

6.10.5 Shanghai RAAS Recent Developments/Updates

6.11 Bharat Serum

6.11.1 Bharat Serum Company Information

6.11.2 Bharat Serum Description and Business Overview

6.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolio

6.11.5 Bharat Serum Recent Developments/Updates

6.12 VINS

6.12.1 VINS Company Information

6.12.2 VINS Description and Business Overview

6.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)

6.12.4 VINS Human Rabies Immunoglobulin (IM) Product Portfolio

6.12.5 VINS Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Rabies Immunoglobulin (IM) Industry Chain Analysis

7.2 Human Rabies Immunoglobulin (IM) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Rabies Immunoglobulin (IM) Production Mode & Process Analysis

7.4 Human Rabies Immunoglobulin (IM) Sales and Marketing

7.4.1 Human Rabies Immunoglobulin (IM) Sales Channels

7.4.2 Human Rabies Immunoglobulin (IM) Distributors

7.5 Human Rabies Immunoglobulin (IM) Customer Analysis

8 Human Rabies Immunoglobulin (IM) Market Dynamics

8.1 Human Rabies Immunoglobulin (IM) Industry Trends

8.2 Human Rabies Immunoglobulin (IM) Market Drivers

8.3 Human Rabies Immunoglobulin (IM) Market Challenges

8.4 Human Rabies Immunoglobulin (IM) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sichuan Yuanda Shuyang

List of Tables

Table 1. Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Human Rabies Immunoglobulin (IM) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Human Rabies Immunoglobulin (IM) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Human Rabies Immunoglobulin (IM) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Human Rabies Immunoglobulin (IM) Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Human Rabies Immunoglobulin (IM), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application

Table 12. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)

Table 18. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2025)

Table 19. Global Human Rabies Immunoglobulin (IM) Sales by Region (2026-2031) & (K Units)

Table 20. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2026-2031)

Table 21. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2025)

Table 23. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2026-2031)

Table 25. North America Human Rabies Immunoglobulin (IM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)

Table 27. North America Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)

Table 28. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Human Rabies Immunoglobulin (IM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2020-2025)

Table 51. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2026-2031)

Table 52. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)

Table 53. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2026-2031)

Table 54. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2025)

Table 57. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2026-2031)

Table 58. Global Human Rabies Immunoglobulin (IM) Price (US$/Unit) by Type (2020-2025)

Table 59. Global Human Rabies Immunoglobulin (IM) Price (US$/Unit) by Type (2026-2031)

Table 60. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2020-2025)

Table 61. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2026-2031)

Table 62. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)

Table 63. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2026-2031)

Table 64. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2020-2025)

Table 67. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2026-2031)

Table 68. Global Human Rabies Immunoglobulin (IM) Price (US$/Unit) by Application (2020-2025)

Table 69. Global Human Rabies Immunoglobulin (IM) Price (US$/Unit) by Application (2026-2031)

Table 70. CSL Behring Company Information

Table 71. CSL Behring Description and Business Overview

Table 72. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. CSL Behring Human Rabies Immunoglobulin (IM) Product

Table 74. CSL Behring Recent Developments/Updates

Table 75. Grifols Company Information

Table 76. Grifols Description and Business Overview

Table 77. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Grifols Human Rabies Immunoglobulin (IM) Product

Table 79. Grifols Recent Developments/Updates

Table 80. Sanofi Company Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Sanofi Human Rabies Immunoglobulin (IM) Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Sichuan Yuanda Shuyang Company Information

Table 86. Sichuan Yuanda Shuyang Description and Business Overview

Table 87. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product

Table 89. Sichuan Yuanda Shuyang Recent Developments/Updates

Table 90. Tiantan Bio Company Information

Table 91. Tiantan Bio Description and Business Overview

Table 92. Tiantan Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Tiantan Bio Human Rabies Immunoglobulin (IM) Product

Table 94. Tiantan Bio Recent Developments/Updates

Table 95. Kamada Company Information

Table 96. Kamada Description and Business Overview

Table 97. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Kamada Human Rabies Immunoglobulin (IM) Product

Table 99. Kamada Recent Developments/Updates

Table 100. CBPO Company Information

Table 101. CBPO Description and Business Overview

Table 102. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. CBPO Human Rabies Immunoglobulin (IM) Product

Table 104. CBPO Recent Developments/Updates

Table 105. Shuanglin Bio Company Information

Table 106. Shuanglin Bio Description and Business Overview

Table 107. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product

Table 109. Shuanglin Bio Recent Developments/Updates

Table 110. Weiguang Bio Company Information

Table 111. Weiguang Bio Description and Business Overview

Table 112. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Weiguang Bio Human Rabies Immunoglobulin (IM) Product

Table 114. Weiguang Bio Recent Developments/Updates

Table 115. Shanghai RAAS Company Information

Table 116. Shanghai RAAS Description and Business Overview

Table 117. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product

Table 119. Shanghai RAAS Recent Developments/Updates

Table 120. Bharat Serum Company Information

Table 121. Bharat Serum Description and Business Overview

Table 122. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Bharat Serum Human Rabies Immunoglobulin (IM) Product

Table 124. Bharat Serum Recent Developments/Updates

Table 125. VINS Company Information

Table 126. VINS Description and Business Overview

Table 127. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. VINS Human Rabies Immunoglobulin (IM) Product

Table 129. VINS Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Human Rabies Immunoglobulin (IM) Distributors List

Table 133. Human Rabies Immunoglobulin (IM) Customers List

Table 134. Human Rabies Immunoglobulin (IM) Market Trends

Table 135. Human Rabies Immunoglobulin (IM) Market Drivers

Table 136. Human Rabies Immunoglobulin (IM) Market Challenges

Table 137. Human Rabies Immunoglobulin (IM) Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Human Rabies Immunoglobulin (IM)

Figure 2. Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Rabies Immunoglobulin (IM) Market Share by Type: 2024 & 2031

Figure 4. ERIG Product Picture

Figure 5. HRIG Product Picture

Figure 6. Global Human Rabies Immunoglobulin (IM) Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Human Rabies Immunoglobulin (IM) Market Share by Application: 2024 & 2031

Figure 8. Category II Exposure

Figure 9. Category III Exposure

Figure 10. Global Human Rabies Immunoglobulin (IM) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Human Rabies Immunoglobulin (IM) Market Size (2020-2031) & (US$ Million)

Figure 12. Global Human Rabies Immunoglobulin (IM) Sales (2020-2031) & (K Units)

Figure 13. Global Human Rabies Immunoglobulin (IM) Average Price (US$/Unit) & (2020-2031)

Figure 14. Human Rabies Immunoglobulin (IM) Report Years Considered

Figure 15. Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers in 2024

Figure 16. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Human Rabies Immunoglobulin (IM) Players: Market Share by Revenue in Human Rabies Immunoglobulin (IM) in 2024

Figure 18. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)

Figure 21. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)

Figure 25. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)

Figure 26. Germany Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2031)

Figure 33. China Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)

Figure 44. Latin America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. U.A.E Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Human Rabies Immunoglobulin (IM) by Type (2020-2031)

Figure 54. Global Revenue Market Share of Human Rabies Immunoglobulin (IM) by Type (2020-2031)

Figure 55. Global Human Rabies Immunoglobulin (IM) Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Human Rabies Immunoglobulin (IM) by Application (2020-2031)

Figure 57. Global Revenue Market Share of Human Rabies Immunoglobulin (IM) by Application (2020-2031)

Figure 58. Global Human Rabies Immunoglobulin (IM) Price (US$/Unit) by Application (2020-2031)

Figure 59. Human Rabies Immunoglobulin (IM) Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-11140

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Beta-lactam and Beta-lactamase Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38G9024

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Infectious Disease Testing Instrumentation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-13164

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Avian Influenza Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-11161

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Human Rabies Immunoglobulin (IM) Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-39X8702

Global Human Rabies Immunoglobulin (IM) Market Research Report 2025

FEATURED COMPANIES

Human Rabies Immunoglobulin (IM) Market Size

Human Rabies Immunoglobulin (IM) Market

Report Scope

Scope of Human Rabies Immunoglobulin (IM) Market Report

Core Chapters

FAQ for this report

How fast is Human Rabies Immunoglobulin (IM) Market growing?

What is the Human Rabies Immunoglobulin (IM) Market size in 2031?

Who are the main players in the Human Rabies Immunoglobulin (IM) Market report?

What are the Application segmentation covered in the Human Rabies Immunoglobulin (IM) Market report?

What are the Type segmentation covered in the Human Rabies Immunoglobulin (IM) Market report?

FEATURED COMPANIES

RELATED REPORTS

$8000

Enterprise User

$5800

Enterprise User

$8000

Enterprise User

$8000

Enterprise User